Sponsor or institution
Clinical trials and research at Getz Pharma
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Getz Pharma that are recruiting, at sites in 5 countries (most in Pakistan (2), Afghanistan (1), Kenya (1)). By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Effects of Ertugliflozin on liver fat and diabetes control in patients with fatty liver disease
This study is testing if the medication Ertugliflozin can help adults with Type 2 Diabetes and fatty liver disease reduce liver fat and improve their blood sugar control.
-
Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes
This project will try empagliflozin, with or without metformin, in adults with Type 2 diabetes to see if it is safe and well tolerated in routine clinical care at participating centers.
Quick answers
How many clinical trials run by Getz Pharma are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Pakistan (2 trials), Afghanistan (1 trial), Kenya (1 trial), Nigeria (1 trial), Sri Lanka (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.